CellSeed Inc. (TYO:7776)
155.00
0.00 (0.00%)
Nov 18, 2026, 10:19 AM JST
CellSeed Revenue
In the year 2021, CellSeed had annual revenue of 161.00M JPY, down -19.10%. CellSeed had revenue of 33.00M in the quarter ending December 31, 2021, a decrease of -71.55%. That makes CellSeed the 43,633rd largest company in the world by revenue and 3,861st in Japan.
Revenue
161.00M
Revenue Growth
-19.10%
P/S Ratio
38.07
Revenue / Employee
3.66M
Employees
44
Market Cap
6.13B
Revenue by Segment
Fiscal year ended Dec 31, 2021
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 161.00M | -38.00M | -19.10% |
| Dec 31, 2020 | 199.00M | -76.00M | -27.64% |
| Dec 31, 2019 | 275.00M | -751.00M | -73.20% |
| Dec 31, 2018 | 1.03B | 941.00M | 1,107.06% |
| Dec 31, 2017 | 85.00M | -15.00M | -15.00% |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Kidswell Bio | 5.79B |
| CellSource | 3.67B |
| Soiken Holdings | 3.24B |
| StemCell Institute | 2.81B |
| Carna Biosciences | 756.57M |
| OncoTherapy Science | 712.00M |
| Chiome Bioscience | 615.15M |
| Nano Holdings | 210.00M |